Sichuan Huiyu Pharmaceutical Co., Ltd
Clinical trials sponsored by Sichuan Huiyu Pharmaceutical Co., Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a new iron injection match the standard treatment? Results expected Sep 2026 (estimated)
- New pill targets Hard-to-Treat KRAS cancers in early human trial Results expected Dec 2026 (estimated)
- New Fat-Melting injection for double chin enters human testing Results expected Dec 2026 (estimated)
- New cancer drug HY0001a enters human trials for advanced solid tumors Results expected Jun 2027 (estimated)
-
Generic antifungal drug shows promise in early comparison study
Knowledge-focused CompletedThis study compared a new generic version of liposomal amphotericin B (an antifungal drug) to the brand-name version (AmBisome®) in 58 healthy Chinese adults. Each volunteer received a single dose of both drugs at different times to see if the generic works the same way in the bo…
Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Generic antifungal drug put to the test in healthy volunteers
Knowledge-focused CompletedThis study checked if a new version of the antifungal drug amphotericin B liposome works the same as the original. 42 healthy adults received a single dose of each version at different times. The goal was to see if the drug levels in the blood were similar enough to consider the …
Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC